Tennessee Pauses Executions After Pike Survives Lethal Injection

Christa Pike, convicted in 1996 for the 1995 murder of Colleen Slemmer, remained alive and unconscious on a ventilator after Tennessee officials administered two doses of pentobarbital during a lethal injection on October 1, 2026. The procedure at Riverbend Maximum Security Institution was halted when the drugs failed to cause death, prompting her transfer to a hospital. Pike, now 50, had requested a firing squad instead, citing fears of injection pain, but that option was denied.

The failed attempt marked the second problematic execution under state corrections commissioner Frank Strada this year. In May, officials struggled for over an hour to locate a vein for Tony Carruthers before stopping the process. Strada previously oversaw three Arizona executions in 2022 that defense attorneys and the Death Penalty Information Center described as prolonged due to IV access difficulties, including groin incisions in one case. Tennessee Governor Bill Lee suspended all executions through December and ordered an independent review, stating the department followed protocol.

Pike’s attorneys labeled the event chemical torture and questioned whether the pentobarbital had degraded or entered surrounding tissue rather than the bloodstream. They noted her history of childhood abuse and mental illness. The Death Penalty Information Center reported at least 203 exonerations from death row since 1973 and noted Black individuals comprise 40 percent of current death row inmates despite being 12 percent of the population. National executions fell from 98 in 1999 to 22 in 2019 before rising to 47 last year, driven largely by Florida.

Lee’s office declined to address Strada’s prior record directly. A 2022 state-commissioned report had already flagged Tennessee’s inadequate drug testing and protocol adherence before Strada’s appointment. Strada’s deposition responses indicated success was defined solely by the inmate’s death, with no additional criteria. Candidates seeking to replace Lee have signaled they would not retain him. The state continues to withhold details on drug suppliers and team training requirements.